Rank #1178GH

Guardant Health, Inc.

$106.38

-0.97% (Daily)

Market Cap

$13.82B

Revenue

$902.57M

Rank by MCap

#1178

Sector

Healthcare

Industry

Diagnostics & Research

CEO

Dr. Helmy Eltoukhy Ph.D.

Headquarters

Palo Alto, CA

Employees

1,999

About Guardant Health, Inc.

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company provides precision oncology testing services comprising Guardant360, a panel of genetic tests; Guardant360 LDT that measures 730+ genes and supports all guideline-recommended biomarkers; Guardant360 CDx Test, a liquid biopsy test; Guardant360 Response Test, a blood-only liquid biopsy; Guardant360 TissueNext Test, a tissue-based test with AI-...